Choksi Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 73.7 million compared to INR 61.67 million a year ago. Revenue was INR 73.73 million compared to INR 63.78 million a year ago. Net income was INR 0.286 million compared to net loss of INR 10.78 million a year ago. Basic earnings per share from continuing operations was INR 0.04 compared to basic loss per share from continuing operations of INR 1.55 a year ago. Diluted earnings per share from continuing operations was INR 0.04 compared to diluted loss per share from continuing operations of INR 1.55 a year ago.
For the nine months, sales was INR 199.04 million compared to INR 183.43 million a year ago. Revenue was INR 200.02 million compared to INR 188.06 million a year ago. Net loss was INR 20.32 million compared to INR 22.18 million a year ago. Basic loss per share from continuing operations was INR 2.92 compared to INR 3.18 a year ago. Diluted loss per share from continuing operations was INR 2.92 compared to INR 3.18 a year ago.